{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:31:56Z","timestamp":1790188316286,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Health and Labor Sciences Research Grant","award":["21445722"],"award-info":[{"award-number":["21445722"]}]},{"name":"Health and Labor Sciences Research Grant","award":["21445722"],"award-info":[{"award-number":["21445722"]}]},{"name":"Health and Labor Sciences Research Grant","award":["21445722"],"award-info":[{"award-number":["21445722"]}]},{"name":"Health and Labor Sciences Research Grant","award":["21445722"],"award-info":[{"award-number":["21445722"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-025-01707-9","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T17:15:33Z","timestamp":1739294133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of curative radiotherapy for the treatment of elderly patients with muscle-invasive bladder cancer: a systematic review"],"prefix":"10.1186","volume":"25","author":[{"given":"Masakuni","family":"Sakaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Maebayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Sekino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"4","key":"1707_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-043266","volume":"11","author":"SL Maibom","year":"2021","unstructured":"Maibom SL, Joensen UN, Poulsen AM, Kehlet H, Brasso K, R\u00f8der MA. Short-term morbidity and mortality following radical cystectomy: a systematic review. BMJ Open. 2021;11(4): e043266. https:\/\/doi.org\/10.1136\/bmjopen-2020-043266. PMID:33853799;PMCID:PMC8054090.","journal-title":"BMJ Open"},{"issue":"1","key":"1707_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12894-022-01084-7","volume":"22","author":"YS Tsai","year":"2022","unstructured":"Tsai YS, Wu TY, Ou CH, Cheng HL, Tzai TS, Yang WH, et al. Dynamic changes of quality of life in muscle-invasive bladder cancer survivors. BMC Urol. 2022;22(1):126. https:\/\/doi.org\/10.1186\/s12894-022-01084-7. PMID:35987634;PMCID:PMC9392945.","journal-title":"BMC Urol"},{"issue":"20","key":"1707_CR3","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1200\/JCO.2016.69.2327","volume":"35","author":"GS Kulkarni","year":"2017","unstructured":"Kulkarni GS, Hermanns T, Wei Y, Bhindi B, Satkunasivam R, Athanasopoulos P, et al. Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic. J Clin Oncol. 2017;35(20):2299\u2013305. https:\/\/doi.org\/10.1200\/JCO.2016.69.2327. (Epub 2017 Apr 14 PMID: 28410011).","journal-title":"J Clin Oncol"},{"issue":"4","key":"1707_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fonc.2014.00206","volume":"5","author":"GA Turgeon","year":"2014","unstructured":"Turgeon GA, Souhami L. Trimodality therapy for bladder preservation in the elderly population with invasive bladder cancer. Front Oncol. 2014;5(4):206. https:\/\/doi.org\/10.3389\/fonc.2014.00206. PMID:25140295;PMCID:PMC4122205.","journal-title":"Front Oncol"},{"issue":"4","key":"1707_CR5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.21873\/invivo.11125","volume":"31","author":"L Manig","year":"2017","unstructured":"Manig L, Janssen S, Schild SE, Rades D. A new prognostic tool for patients undergoing radiotherapy plus upfront transurethral resection for bladder cancer. In Vivo. 2017;31(4):745\u20138. https:\/\/doi.org\/10.21873\/invivo.11125.","journal-title":"In Vivo"},{"issue":"34","key":"1707_CR6","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1200\/JCO.2014.57.5548","volume":"32","author":"RH Mak","year":"2014","unstructured":"Mak RH, Hunt D, Shipley WU, Efstathiou JA, Tester WJ, Hagan MP, et al. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233. J Clin Oncol. 2014;32(34):3801\u20139. https:\/\/doi.org\/10.1200\/JCO.2014.57.5548.","journal-title":"J Clin Oncol"},{"key":"1707_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/1748-717X-9-213","volume":"9","author":"CY Lee","year":"2014","unstructured":"Lee CY, Yang KL, Ko HL, Huang RY, Tsai PP, Chen MT, et al. Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival. Radiat Oncol. 2014;9:213. https:\/\/doi.org\/10.1186\/1748-717X-9-213.","journal-title":"Radiat Oncol"},{"issue":"3","key":"1707_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.radonc.2018.05.022","volume":"129","author":"M Christodoulou","year":"2018","unstructured":"Christodoulou M, Reeves KJ, Hodgson C, Zeniou A, Slevin F, Kennedy J, et al. Outcomes of radiosensitisation in elderly patients with advanced bladder cancer. Radiother Oncol. 2018;129(3):499\u2013506. https:\/\/doi.org\/10.1016\/j.radonc.2018.05.022.","journal-title":"Radiother Oncol"},{"issue":"4","key":"1707_CR9","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3892\/ijo.2013.2058","volume":"43","author":"H Azuma","year":"2013","unstructured":"Azuma H, Inamoto T, Takahara K, Nomi H, Hirano H, Uehara H, et al. A great option for elderly patients with locally invasive bladder cancer, BOAI-CDDP-radiation (OMC regimen). Int J Oncol. 2013;43(4):1087\u201394. https:\/\/doi.org\/10.3892\/ijo.2013.2058.","journal-title":"Int J Oncol"},{"issue":"5","key":"1707_CR10","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/s0360-3016(99)00306-5","volume":"45","author":"CR Hayter","year":"1999","unstructured":"Hayter CR, Paszat LF, Groome PA, Schulze K, Math M, Mackillop WJ. A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer. Int J Radiat Oncol Biol Phys. 1999;45(5):1239\u201345. https:\/\/doi.org\/10.1016\/s0360-3016(99)00306-5.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1707_CR11","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/ijc.28716","volume":"135","author":"CA Goossens-Laan","year":"2014","unstructured":"Goossens-Laan CA, Leliveld AM, Verhoeven RH, Kil PJ, de Bock GH, Hulshof MC, et al. Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer. 2014;135(4):905\u201312. https:\/\/doi.org\/10.1002\/ijc.28716.","journal-title":"Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer"},{"issue":"10","key":"1707_CR12","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1002\/1097-0142(19931115)72:10<3036::aid-cncr2820721028>3.0.co;2-b","volume":"72","author":"SD Foss\u00e5","year":"1993","unstructured":"Foss\u00e5 SD, Waehre H, Aass A, Jacobsen AB, Olsen DR, Ous S. Bladder cancer definitive radiation therapy of muscle-invasive bladder cancer. A retrospective analysis of 317 patients. Cancer. 1993;72(10):3036\u201343. https:\/\/doi.org\/10.1002\/1097-0142(19931115)72:10<3036::aid-cncr2820721028>3.0.co;2-b.","journal-title":"Cancer."},{"issue":"6","key":"1707_CR13","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.21873\/anticanres.11694","volume":"37","author":"S Janssen","year":"2017","unstructured":"Janssen S, Manig L, Schild SE, Rades D. Radiotherapy of Primary or Recurrent Bladder Cancer in the Very Elderly. Anticancer Res. 2017;37(6):3287\u201390. https:\/\/doi.org\/10.21873\/anticanres.11694.","journal-title":"Anticancer Res"},{"issue":"4","key":"1707_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jgo.2015.04.004","volume":"6","author":"E Canyilmaz","year":"2015","unstructured":"Canyilmaz E, Yoney A, Serdar L, Uslu GH, Aynaci O, Haciislamoglu E, et al. Long-term results of a concomitant boost radiotherapy technique for elderly patients with muscle-invasive bladder cancer. J Geriatr Oncol. 2015;6(4):316\u201323. https:\/\/doi.org\/10.1016\/j.jgo.2015.04.004.","journal-title":"J Geriatr Oncol"},{"issue":"25","key":"1707_CR15","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1200\/JCO.2008.19.5776","volume":"27","author":"JA Efstathiou","year":"2009","unstructured":"Efstathiou JA, Bae K, Shipley WU, Kaufman DS, Hagan MP, Heney NM, et al. Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89\u201303, 95\u201306, 97\u201306, 99\u201306. J Clin Oncol. 2009;27(25):4055\u201361. https:\/\/doi.org\/10.1200\/JCO.2008.19.5776.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1707_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00066-021-01837-7","volume":"198","author":"CR Arnold","year":"2022","unstructured":"Arnold CR, Lindner AK, Schachtner G, Tulchiner N, Mangesius J, Maffei M, et al. Vinorelbine in bladder-preserving multimodality treatment for muscle-invasive bladder cancer-a valid option for cisplatin-unfit patients. Strahlenther Onkol. 2022;198(1):25\u201332. https:\/\/doi.org\/10.1007\/s00066-021-01837-7.","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"1707_CR17","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ijrobp.2013.11.005","volume":"88","author":"GA Turgeon","year":"2014","unstructured":"Turgeon GA, Souhami L, Cury FL, Faria SL, Duclos M, Sturgeon J, et al. Hypofractionated intensity modulated radiation therapy in combined modality treatment for bladder preservation in elderly patients with invasive bladder cancer. Int J Radiat Oncol Biol Phys. 2014;88(2):326\u201331. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.11.005.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1707_CR18","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jgo.2018.10.015","volume":"10","author":"C Wujanto","year":"2019","unstructured":"Wujanto C, Tey J, Chia D, Ho F, Ooi KH, Wong AS, et al. Radical radiotherapy in older patients with muscle invasive bladder cancer. J Geriatr Oncol. 2019;10(2):292\u20137. https:\/\/doi.org\/10.1016\/j.jgo.2018.10.015.","journal-title":"J Geriatr Oncol"},{"issue":"9","key":"1707_CR19","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.21873\/anticanres.11033","volume":"36","author":"T Maebayashi","year":"2016","unstructured":"Maebayashi T, Ishibashi N, Aizawa T, Sakaguchi M, Sato K, Matsui T, et al. Radiotherapy for muscle-invasive bladder cancer in very elderly patients. Anticancer Res. 2016;36(9):4763\u20139. https:\/\/doi.org\/10.21873\/anticanres.11033.","journal-title":"Anticancer Res"},{"issue":"2","key":"1707_CR20","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.juro.2017.08.086","volume":"199","author":"BW Fischer-Valuck","year":"2018","unstructured":"Fischer-Valuck BW, Rao YJ, Rudra S, Przybysz D, Germino E, Samson P, et al. Treatment patterns and overall survival outcomes of octogenarians with muscle invasive cancer of the bladder: an analysis of the national cancer database. J Urol. 2018;199(2):416\u201323. https:\/\/doi.org\/10.1016\/j.juro.2017.08.086.","journal-title":"J Urol"},{"key":"1707_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13014-016-0618-6","volume":"11","author":"LJ Lutkenhaus","year":"2016","unstructured":"Lutkenhaus LJ, van Os RM, Bel A, Hulshof MC. Clinical results of conformal versus intensity-modulated radiotherapy using a focal simultaneous boost for muscle-invasive bladder cancer in elderly or medically unfit patients. Radiat Oncol. 2016;11:45. https:\/\/doi.org\/10.1186\/s13014-016-0618-6.","journal-title":"Radiat Oncol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01707-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01707-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01707-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T17:15:38Z","timestamp":1739294138000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01707-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1707"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01707-9","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"5 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}